In conclusion, these findings all support a potential oncogenic role of the SPHK1/S1P axis in lung diseases, and understanding its carcinogenic mechanism may bring new insights into the treatment of NSCLC or other diseases. This evidence concerns the gene MBTPS1 and non-small cell lung carcinoma.